Dyadic International Inc. (NASDAQ:DYAI – Get Free Report) was the recipient of a significant decline in short interest in October. As of October 30th, there was short interest totaling 83,236 shares, a decline of 57.3% from the October 15th total of 194,728 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average trading volume of 83,778 shares, the days-to-cover ratio is currently 1.0 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded shares of Dyadic International from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 16th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.
Read Our Latest Stock Report on DYAI
Dyadic International Trading Down 6.6%
Shares of NASDAQ:DYAI traded down $0.02 during trading on Friday, reaching $0.33. The stock had a trading volume of 189,367 shares, compared to its average volume of 83,523. Dyadic International has a one year low of $0.32 and a one year high of $1.60. The company has a market capitalization of $13.10 million, a P/E ratio of -1.56 and a beta of 1.10. The firm’s 50-day simple moving average is $0.42 and its 200 day simple moving average is $0.74.
Dyadic International (NASDAQ:DYAI – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The biotechnology company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.01). The firm had revenue of $0.45 million for the quarter, compared to the consensus estimate of $1.43 million. Dyadic International had a negative return on equity of 2,920.31% and a negative net margin of 226.85%. Equities research analysts forecast that Dyadic International will post -0.15 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Dyadic International
An institutional investor recently bought a new stake in Dyadic International stock. Landscape Capital Management L.L.C. acquired a new stake in shares of Dyadic International Inc. (NASDAQ:DYAI – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 55,263 shares of the biotechnology company’s stock, valued at approximately $50,000. Landscape Capital Management L.L.C. owned about 0.15% of Dyadic International at the end of the most recent quarter. Institutional investors and hedge funds own 27.95% of the company’s stock.
Dyadic International Company Profile
Dyadic International is a biotechnology company developing microbial expression systems to produce proteins for human and animal health applications. Its platforms are designed to help partners develop and manufacture biologics, including vaccines, therapeutics and diagnostic products. The company’s technologies include its C1 fungal expression system, based on a non-pathogenic microorganism, and its Dapibus yeast platform. Dyadic licenses these systems and related expertise to collaborators and also pursues development of selected products for health applications.
Recommended Stories
- Five stocks we like better than Dyadic International
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Dyadic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International and related companies with MarketBeat.com's FREE daily email newsletter.
